• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Molina Healthcare Inc filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

    5/1/25 4:17:16 PM ET
    $MOH
    Medical Specialities
    Health Care
    Get the next $MOH alert in real time by email
    moh-20250430
    0001179929false00011799292025-05-012025-05-01

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    ______________
    FORM 8-K
    ______________
    Current Report
    Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
    Date of Report (Date of earliest event reported): April 30, 2025
    ______________
    MOLINA HEALTHCARE, INC.
    (Exact name of registrant as specified in its charter)
    Delaware1-3171913-4204626
    (State or other jurisdiction of incorporation)(Commission File Number)(IRS Employer Identification No.)
    ______________
    200 Oceangate, Suite 100,Long Beach,California90802
    (Address of principal executive offices)(Zip Code)
    Registrant’s telephone number, including area code: (562) 435-3666
    N/A
    (Former name or former address, if changed since last report.)
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
    Securities registered pursuant to Section 12(b) of the Act:
    Title of each classTrading Symbol(s)Name of each exchange on which registered
    Common Stock, $0.001 Par Value MOHNew York Stock Exchange
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
    Emerging growth company
    ☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
    ☐



    Item 5.02.    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
    On April 30, 2025, as further described in Item 5.07 below, the stockholders of Molina Healthcare, Inc. (the “Company”) approved the Company’s 2025 Equity Incentive Plan (the “2025 Plan”) at the Company’s Annual Meeting of Stockholders (the “Annual Meeting”). The 2025 Plan previously had been approved, subject to stockholder approval, by the Company's Board of Directors.

    A summary of the material terms of the 2025 Plan is set forth in “Proposal 4, Approval of the Molina Healthcare, Inc. 2025 Equity Incentive Plan” in the Company’s definitive proxy statement for the Annual Meeting filed with the Securities and Exchange Commission on March 17, 2025. That summary and the foregoing description of the 2025 Plan are qualified in their entirety by reference to the text of the 2025 Plan, a copy of which is filed as Exhibit 10.1 hereto and incorporated herein by reference

    Item 5.07.    Submission of Matters to a Vote of Security Holders.
    On April 30, 2025, the Company held its Annual Meeting. As of the close of business on March 7, 2025 (the “Record Date”), a total of 54,699,859 shares of the Company’s common stock (the “Common Stock”) were issued and outstanding. At the Annual Meeting, holders of 46,818,689 shares of Common Stock, or 85.6% of shares outstanding on the Record Date, were represented in person or by proxy, constituting a quorum.

    With regard to Proposal No. 1, for the election of the nine directors named below to hold office until the 2026 annual meeting, the stockholders voted as follows:
    DirectorVotes ForVotes AgainstAbstentionsBroker
    Non-Votes
    Barbara L. Brasier44,368,065589,79812,0551,848,771
    Leo P. Grohowski44,750,210206,04013,6681,848,771
    Stephen H. Lockhart 44,845,868112,23811,8121,848,771
    Steven J. Orlando42,139,7122,758,78771,4191,848,771
    Ronna E. Romney 40,038,4254,742,279189,2141,848,771
    Richard M. Schapiro 44,841,652116,68411,5821,848,771
    Dale B. Wolf37,706,4947,152,237111,1871,848,771
    Richard C. Zoretic44,852,360105,73411,8241,848,771
    Joseph M. Zubretsky44,749,858207,41512,6451,848,771
    With regard to Proposal No. 2, for the approval, on a non-binding, advisory basis, of the compensation of the Company’s named executive officers, the stockholders voted as follows:
    Votes ForVotes AgainstAbstentionsBroker Non-Votes
    18,249,70026,653,67266,5461,848,771
    With regard to Proposal No. 3, for the ratification of the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for 2025, the stockholders voted as follows:



    Votes ForVotes AgainstAbstentionsBroker Non-Votes
    44,537,8252,269,16111,7030
    With regard to Proposal No. 4, for the approval of the Company’s 2025 Equity Incentive Plan, the stockholders voted as follows:
    Votes ForVotes AgainstAbstentionsBroker Non-Votes
    43,316,3321,641,31912,2671,848,771
    With regard to Proposal No. 5, for the stockholder proposal regarding the ability of stockholders holding 10% of the Company’s outstanding stock to call a special stockholders meeting, the stockholders voted as follows:
    Votes ForVotes AgainstAbstentionsBroker Non-Votes
    30,991,52813,927,37351,0171,848,771
    Item 9.01.    Financial Statements and Exhibits.
    (d)     Exhibits:
    Exhibit No.Description
    10.1
    Molina Healthcare, Inc. 2025 Equity Incentive Plan
    104Cover Page Interactive Data File (embedded within the Inline XBRL document)



    SIGNATURE
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
    MOLINA HEALTHCARE, INC.
    Date:
    May 1, 2025
    By:
    /s/ Jeff D. Barlow
    Jeff D. Barlow
    Chief Legal Officer and Secretary


    Get the next $MOH alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $MOH

    DatePrice TargetRatingAnalyst
    7/25/2025$210.00Overweight → Neutral
    Cantor Fitzgerald
    7/25/2025$180.00Buy → Hold
    Truist
    7/10/2025$266.00Overweight → Equal-Weight
    Morgan Stanley
    6/9/2025$364.00Overweight
    Morgan Stanley
    4/22/2025$414.00Outperform
    Bernstein
    4/15/2025$375.00Outperform → Neutral
    Robert W. Baird
    3/5/2025$295.00 → $372.00Equal Weight → Overweight
    Wells Fargo
    12/17/2024$378.00 → $350.00Neutral
    Analyst
    More analyst ratings

    $MOH
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Molina Healthcare Reports Second Quarter 2025 Financial Results

      Revises Full Year 2025 Guidance Molina Healthcare, Inc. (NYSE:MOH) (the "Company") today reported second quarter 2025 GAAP earnings per diluted share of $4.75 and adjusted earnings per diluted share of $5.48. Financial results are summarized below:   Three months ended   Six months ended   June 30,   June 30,   2025   2024   2025   2024                 (In millions, except per-share results) Premium Revenue $10,868   $9,446   $21,496   $18,950 Total Revenue $11,427  

      7/23/25 4:15:00 PM ET
      $MOH
      Medical Specialities
      Health Care
    • Molina Healthcare Announces Preliminary Second Quarter Financial Results and Updates Fiscal Year 2025 Earnings Per Share Guidance

      Molina Healthcare, Inc. (NYSE:MOH) today announced preliminary financial results for the second quarter of 2025 and updated its full year 2025 adjusted earnings per share guidance. The Company's announcement of preliminary results was driven by recent market dynamics and off-cycle disclosures from others in the managed health care sector. The Company now expects its second quarter 2025 adjusted earnings to be approximately $5.50 per share(1), which is modestly below its prior expectations. This preliminary result reflects medical cost pressures in all three lines of business. The Company expects these medical cost pressures to continue into the second half of the year. As a result, the Co

      7/7/25 6:30:00 AM ET
      $MOH
      Medical Specialities
      Health Care
    • Molina Healthcare Announces Second Quarter 2025 Earnings Release and Conference Call Dates

      Molina Healthcare, Inc. (NYSE:MOH) today announced it will issue its earnings release for the second quarter ending June 30, 2025, after the market closes on Wednesday, July 23, 2025, and will host a conference call and webcast to discuss the earnings release on Thursday, July 24, 2025, at 8:00 a.m. Eastern Time. To access this interactive teleconference, dial (877) 883-0383 and enter the confirmation number, 4784585. A telephonic replay of the conference call will be available through Thursday, July 31, 2025, by dialing (877) 344-7529 and entering the confirmation number, 9484867. A live broadcast of Molina Healthcare's conference call will be available on the Company's investor relation

      6/4/25 9:00:00 AM ET
      $MOH
      Medical Specialities
      Health Care

    $MOH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Molina Healthcare downgraded by Cantor Fitzgerald with a new price target

      Cantor Fitzgerald downgraded Molina Healthcare from Overweight to Neutral and set a new price target of $210.00

      7/25/25 8:59:40 AM ET
      $MOH
      Medical Specialities
      Health Care
    • Molina Healthcare downgraded by Truist with a new price target

      Truist downgraded Molina Healthcare from Buy to Hold and set a new price target of $180.00

      7/25/25 8:58:38 AM ET
      $MOH
      Medical Specialities
      Health Care
    • Molina Healthcare downgraded by Morgan Stanley with a new price target

      Morgan Stanley downgraded Molina Healthcare from Overweight to Equal-Weight and set a new price target of $266.00

      7/10/25 8:36:12 AM ET
      $MOH
      Medical Specialities
      Health Care

    $MOH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Operating Officer Woys James was granted 85 shares, increasing direct ownership by 0.13% to 64,331 units (SEC Form 4)

      4 - MOLINA HEALTHCARE, INC. (0001179929) (Issuer)

      7/2/25 5:22:55 PM ET
      $MOH
      Medical Specialities
      Health Care
    • Director Zoretic Richard C was granted 180 shares (SEC Form 4)

      4 - MOLINA HEALTHCARE, INC. (0001179929) (Issuer)

      7/2/25 5:22:19 PM ET
      $MOH
      Medical Specialities
      Health Care
    • Director Wolf Dale B was granted 180 shares (SEC Form 4)

      4 - MOLINA HEALTHCARE, INC. (0001179929) (Issuer)

      7/2/25 5:21:24 PM ET
      $MOH
      Medical Specialities
      Health Care

    $MOH
    SEC Filings

    See more
    • SEC Form 10-Q filed by Molina Healthcare Inc

      10-Q - MOLINA HEALTHCARE, INC. (0001179929) (Filer)

      7/24/25 9:49:15 AM ET
      $MOH
      Medical Specialities
      Health Care
    • Molina Healthcare Inc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - MOLINA HEALTHCARE, INC. (0001179929) (Filer)

      7/23/25 4:17:03 PM ET
      $MOH
      Medical Specialities
      Health Care
    • Molina Healthcare Inc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - MOLINA HEALTHCARE, INC. (0001179929) (Filer)

      7/7/25 6:31:21 AM ET
      $MOH
      Medical Specialities
      Health Care

    $MOH
    Financials

    Live finance-specific insights

    See more
    • Molina Healthcare Reports Second Quarter 2025 Financial Results

      Revises Full Year 2025 Guidance Molina Healthcare, Inc. (NYSE:MOH) (the "Company") today reported second quarter 2025 GAAP earnings per diluted share of $4.75 and adjusted earnings per diluted share of $5.48. Financial results are summarized below:   Three months ended   Six months ended   June 30,   June 30,   2025   2024   2025   2024                 (In millions, except per-share results) Premium Revenue $10,868   $9,446   $21,496   $18,950 Total Revenue $11,427  

      7/23/25 4:15:00 PM ET
      $MOH
      Medical Specialities
      Health Care
    • Molina Healthcare Announces Preliminary Second Quarter Financial Results and Updates Fiscal Year 2025 Earnings Per Share Guidance

      Molina Healthcare, Inc. (NYSE:MOH) today announced preliminary financial results for the second quarter of 2025 and updated its full year 2025 adjusted earnings per share guidance. The Company's announcement of preliminary results was driven by recent market dynamics and off-cycle disclosures from others in the managed health care sector. The Company now expects its second quarter 2025 adjusted earnings to be approximately $5.50 per share(1), which is modestly below its prior expectations. This preliminary result reflects medical cost pressures in all three lines of business. The Company expects these medical cost pressures to continue into the second half of the year. As a result, the Co

      7/7/25 6:30:00 AM ET
      $MOH
      Medical Specialities
      Health Care
    • Molina Healthcare Announces Second Quarter 2025 Earnings Release and Conference Call Dates

      Molina Healthcare, Inc. (NYSE:MOH) today announced it will issue its earnings release for the second quarter ending June 30, 2025, after the market closes on Wednesday, July 23, 2025, and will host a conference call and webcast to discuss the earnings release on Thursday, July 24, 2025, at 8:00 a.m. Eastern Time. To access this interactive teleconference, dial (877) 883-0383 and enter the confirmation number, 4784585. A telephonic replay of the conference call will be available through Thursday, July 31, 2025, by dialing (877) 344-7529 and entering the confirmation number, 9484867. A live broadcast of Molina Healthcare's conference call will be available on the Company's investor relation

      6/4/25 9:00:00 AM ET
      $MOH
      Medical Specialities
      Health Care

    $MOH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Molina Healthcare Inc

      SC 13G/A - MOLINA HEALTHCARE, INC. (0001179929) (Subject)

      11/14/24 1:22:34 PM ET
      $MOH
      Medical Specialities
      Health Care
    • SEC Form SC 13G filed by Molina Healthcare Inc

      SC 13G - MOLINA HEALTHCARE, INC. (0001179929) (Subject)

      11/12/24 12:53:29 PM ET
      $MOH
      Medical Specialities
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Molina Healthcare Inc

      SC 13G/A - MOLINA HEALTHCARE, INC. (0001179929) (Subject)

      11/8/24 10:34:33 AM ET
      $MOH
      Medical Specialities
      Health Care